UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission

Nature communications, 2020-12, Vol.11 (1), p.6317-6317, Article 6317

2020

Volltextzugriff (PDF)

Burden of disease and real-world treatment patterns of patients with systemic lupus erythematosus in the Australian OPAL dataset

Clinical rheumatology, 2023-11, Vol.42 (11), p.2971-2980

2023

Volltextzugriff (PDF)

Sex and Pubertal Differences in the Type 1 Interferon Pathway Associate With Both X Chromosome Number and Serum Sex Hormone Concentration

Frontiers in immunology, 2019-01, Vol.9, p.3167-3167

2019

Volltextzugriff (PDF)

Retrospective analysis of infliximab and adalimumab treatment in a large cohort of juvenile dermatomyositis patients

Arthritis research & therapy, 2020-04, Vol.22 (1), p.79-79, Article 79

2020

Volltextzugriff (PDF)

Systemic and Tissue Inflammation in Juvenile Dermatomyositis: From Pathogenesis to the Quest for Monitoring Tools

Frontiers in immunology, 2018-12, Vol.9, p.2951-2951

2018

Volltextzugriff (PDF)

The impact of immunocompromise on outcomes of COVID-19 in children and young people-a systematic review and meta-analysis

Frontiers in immunology, 2023-08, Vol.14, p.1159269

2023

Volltextzugriff (PDF)

Use of Rescue Therapy with IVIG or Cyclophosphamide in Juvenile Myositis

Current rheumatology reports, 2021-03, Vol.23 (4), p.24-24, Article 24

2021

Volltextzugriff (PDF)

Efficacy and Safety of Cyclophosphamide Treatment in Severe Juvenile Dermatomyositis Shown by Marginal Structural Modeling

Arthritis & rheumatology (Hoboken, N.J.), 2018-05, Vol.70 (5), p.785-793

2018

Volltextzugriff (PDF)

Comparative effectiveness of etanercept originator and biosimilar for treating rheumatoid arthritis: implications for cost‐savings

Internal medicine journal, 2024-05, Vol.54 (5), p.795-801

2024

Volltextzugriff (PDF)

Impact of next-generation sequencing error on analysis of barcoded plasmid libraries of known complexity and sequence

Nucleic acids research, 2014-09, Vol.42 (16), p.e129-e129

2014

Volltextzugriff (PDF)

CD19+CD24hiCD38hi B Cells Are Expanded in Juvenile Dermatomyositis and Exhibit a Pro-Inflammatory Phenotype After Activation Through Toll-Like Receptor 7 and Interferon-α

Frontiers in immunology, 2018-06, Vol.9, p.1372-1372

2018

Volltextzugriff (PDF)

Real-world utilisation and switching between Janus kinase inhibitors in Australian patients with rheumatoid arthritis in the OPAL dataset

Clinical and experimental rheumatology, 2024-09

2024

Volltextzugriff (PDF)

Role of CD14+ monocyte-derived oxidised mitochondrial DNA in the inflammatory interferon type 1 signature in juvenile dermatomyositis

Annals of the rheumatic diseases, 2023-05, Vol.82 (5), p.658-669

2023

Volltextzugriff (PDF)

JAK inhibitors: a potential treatment for JDM in the context of the role of interferon-driven pathology

Pediatric rheumatology online journal, 2021-09, Vol.19 (1), p.146-146, Article 146

2021

Volltextzugriff (PDF)

Adalimumab or etanercept as first line biologic therapy in enthesitis related arthritis (ERA) - a drug-survival single centre study spanning 10 years

Seminars in arthritis and rheumatism, 2022-08, Vol.55, p.152038-152038, Article 152038

2022

Volltextzugriff (PDF)

Comparative Effectiveness of First‐Line Baricitinib in Patients With Rheumatoid Arthritis in the Australian OPAL Data Set

ACR open rheumatology, 2023-07, Vol.5 (7), p.345-353

2023

Volltextzugriff (PDF)

Muscle Biopsy Findings in Combination With Myositis‐Specific Autoantibodies Aid Prediction of Outcomes in Juvenile Dermatomyositis

Arthritis & rheumatology (Hoboken, N.J.), 2016-11, Vol.68 (11), p.2806-2816

2016

Volltextzugriff (PDF)

Association with HLA-DRβ1 position 37 distinguishes juvenile dermatomyositis from adult-onset myositis

Human molecular genetics, 2022-07, Vol.31 (14), p.2471-2481

2022

Volltextzugriff (PDF)

Identification and prediction of novel classes of long-term disease trajectories for patients with juvenile dermatomyositis using growth mixture models

Rheumatology (Oxford, England), 2021-04, Vol.60 (4), p.1891-1901

2021

Volltextzugriff (PDF)

Adequacy of percutaneous non-targeted liver biopsy under real-time ultrasound guidance when comparing the Biopince™ and Achieve™ biopsy needle

British journal of radiology, 2017-12, Vol.90 (1080), p.20170397-20170397

2017

Volltextzugriff (PDF)

Clinical signs and symptoms in a joint model of four disease activity parameters in juvenile dermatomyositis: a prospective, longitudinal, multicenter cohort study

Arthritis research & therapy, 2018-08, Vol.20 (1), p.180-180, Article 180

2018

Volltextzugriff (PDF)

A novel electronic patient-reported outcome delivery system to implement health-related quality of life measures in routine clinical care: An analysis of 5 years of experience

Frontiers in digital health, 2023-01, Vol.4, p.1074931-1074931

2023

Volltextzugriff (PDF)

Accepting Risk in Clinical Research: Is the Gene Therapy Field Becoming Too Risk-averse?

Molecular therapy, 2009-11, Vol.17 (11), p.1842-1848

2009

Volltextzugriff (PDF)

1 – 25 von 85

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(70)

Publikationsform

Artikel
(85)

Sprache

Englisch
(85)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission

Burden of disease and real-world treatment patterns of patients with systemic lupus erythematosus in the Australian OPAL dataset

Sex and Pubertal Differences in the Type 1 Interferon Pathway Associate With Both X Chromosome Number and Serum Sex Hormone Concentration

Retrospective analysis of infliximab and adalimumab treatment in a large cohort of juvenile dermatomyositis patients

Systemic and Tissue Inflammation in Juvenile Dermatomyositis: From Pathogenesis to the Quest for Monitoring Tools

The impact of immunocompromise on outcomes of COVID-19 in children and young people-a systematic review and meta-analysis

Use of Rescue Therapy with IVIG or Cyclophosphamide in Juvenile Myositis

Galectin‐9 and CXCL10 as Biomarkers for Disease Activity in Juvenile Dermatomyositis: A Longitudinal Cohort Study and Multicohort Validation

Efficacy and Safety of Cyclophosphamide Treatment in Severe Juvenile Dermatomyositis Shown by Marginal Structural Modeling

Comparative effectiveness of etanercept originator and biosimilar for treating rheumatoid arthritis: implications for cost‐savings

Impact of next-generation sequencing error on analysis of barcoded plasmid libraries of known complexity and sequence

CD19+CD24hiCD38hi B Cells Are Expanded in Juvenile Dermatomyositis and Exhibit a Pro-Inflammatory Phenotype After Activation Through Toll-Like Receptor 7 and Interferon-α

Real-world utilisation and switching between Janus kinase inhibitors in Australian patients with rheumatoid arthritis in the OPAL dataset

Role of CD14+ monocyte-derived oxidised mitochondrial DNA in the inflammatory interferon type 1 signature in juvenile dermatomyositis

Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups

JAK inhibitors: a potential treatment for JDM in the context of the role of interferon-driven pathology

Adalimumab or etanercept as first line biologic therapy in enthesitis related arthritis (ERA) - a drug-survival single centre study spanning 10 years

Comparative Effectiveness of First‐Line Baricitinib in Patients With Rheumatoid Arthritis in the Australian OPAL Data Set

Muscle Biopsy Findings in Combination With Myositis‐Specific Autoantibodies Aid Prediction of Outcomes in Juvenile Dermatomyositis

Association with HLA-DRβ1 position 37 distinguishes juvenile dermatomyositis from adult-onset myositis

Identification and prediction of novel classes of long-term disease trajectories for patients with juvenile dermatomyositis using growth mixture models

Adequacy of percutaneous non-targeted liver biopsy under real-time ultrasound guidance when comparing the Biopince™ and Achieve™ biopsy needle

Clinical signs and symptoms in a joint model of four disease activity parameters in juvenile dermatomyositis: a prospective, longitudinal, multicenter cohort study

A novel electronic patient-reported outcome delivery system to implement health-related quality of life measures in routine clinical care: An analysis of 5 years of experience

Accepting Risk in Clinical Research: Is the Gene Therapy Field Becoming Too Risk-averse?

Suchergebnisse filtern